Filed pursuant to Rule 424(b)(5)
Registration Statement No. 333-265842
Prospectus Supplement
(To Prospectus dated July 7,
2022)
FTC SOLAR, INC.
Up to $11,350,576
Common
Stock
We have entered into an At the Market Offering Agreement dated as of May 1, 2025 (the Sales Agreement) with
H.C. Wainwright & Co., LLC (the Manager or Wainwright), relating to the sale of shares of our common stock, $0.0001 par value per share (the common stock). In accordance with the terms of the
Sales Agreement, from time to time we may offer and sell shares of our common stock through the Manager acting as sales agent and/or principal. Pursuant to this prospectus supplement and the accompanying base prospectus, from time to time we may
offer and sell shares of our common stock having an aggregate offering price of up to $11,350,576.
Sales of our common stock, if any,
under this prospectus supplement and the accompanying base prospectus may be made in sales deemed to be an at the market offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the Securities
Act), including sales made directly on or through the Nasdaq Capital Market (Nasdaq), the existing trading market for our common stock, or any other existing trading market in the United States for our common stock, sales made to
or through a market maker other than on an exchange or otherwise, directly to the Manager as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or in any
other method permitted by law. Subject to terms of the Sales Agreement, the Manager is not required to sell any specific number or dollar amounts of securities, but will act as a sales agent using commercially reasonable efforts consistent with its
normal trading and sales practices, on mutually agreed terms between the Manager and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
The Manager will be entitled to compensation under the terms of the Sales Agreement at a commission rate of up to 3.0% of the gross sales price
per share sold. In connection with the sale of our shares of common stock on our behalf, the Manager will be deemed to be an underwriter within the meaning of the Securities Act and the compensation of the Manager will be deemed to be
underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to the Manager with respect to certain liabilities, including liabilities under the Securities Act. See the section titled Plan of
Distribution on page S-18 of this prospectus supplement.
We will pay all of the
expenses incident to the registration, offering and sale of the shares of common stock under this prospectus supplement and the accompanying base prospectus.
Our common stock is listed and trades on the Nasdaq Capital Market under the symbol FTCI. The last sale price of our shares of
common stock on April 29, 2025 was $3.42 per share.
As of the date of this prospectus supplement, the aggregate market value of our
outstanding common stock held by non-affiliates, computed by reference to the price at which our common stock was last sold on the Nasdaq Capital Market on April 29, 2025, which was $3.42 per share, was
$11,350,576, based on 9,966,612 shares of our outstanding common stock as of the date of this prospectus supplement, of which 6,861,675 shares were held by non-affiliates. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell
securities in a public primary offering with a value exceeding one-third of our public float in any 12-month period so long as our public float remains below $75 million. During the
12 calendar months prior to and including the date of this prospectus supplement (excluding this offering), we have sold approximately $0 of
securities pursuant to General Instruction I.B.6 of Form S-3.
Investing in our shares of common stock involves a high degree of risk. Before making any investment decision, you should carefully review
and consider all the information in this prospectus supplement, the accompanying base prospectus and the documents incorporated by reference herein and therein, including the risks and uncertainties described under Risk Factors beginning on page S-10 of this prospectus supplement and the risk factors incorporated by reference into this prospectus supplement and the accompanying base prospectus.
Neither the U.S. Securities and Exchange Commission (the SEC) nor any state securities commission has approved or disapproved of
these shares or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
H.C. Wainwright & Co.
The date of this prospectus supplement is May 1, 2025.